Could a daily cannabinoid pill tame tourette tics?

NCT ID NCT05126888

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a daily oral medication called SCI-110, made from cannabinoids, to see if it can safely reduce tics in adults with Tourette syndrome. About 164 adults aged 18 to 65 with moderate to severe tics will receive either the drug or a placebo, then switch after 12 weeks. The main goal is to measure changes in tic severity using a standard rating scale.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TOURETTE SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Tourette syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Medizinische Hochschule Hannover

    Hanover, 30625, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Neurological Institute, Tel Aviv Sourasky Medical Center

    Tel Aviv, 64239, Israel

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Yale Child Study Center - NIHB 205

    New Haven, Connecticut, 06519, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••